Current views on metabolic syndrome

Czech version

Authors: Štěpán Svačina
Authors‘ workplace: III. interní klinika – klinika endokrinologie a metabolizmu 1. LF UK a VFN v Praze
Published in: Vnitř Lék 2018; 64(12): 1156-1159
Category:

Overview

The theory of metabolic syndrome originated 30 years ago. Several definitions try to explain the frequent common incidence of the risk factors for atherosclerosis. At first the syndrome of insulin resistance was involved. It was only later that the relation of the metabolic syndrome was described to what is known as systemic inflammation arising in adipose tissue and inflammatory diseases such as chronic bronchitis or psoriasis, or to degenerative diseases such as Alzheimer’s disease. The views on the metabolic syndrome are thus constantly changing.

Key words:

adipose tissue inflammation – definition of metabolic syndrome – insulin resistance – myokines – systemic inflammation

Sources

Svačina Š. Obezitologie a teorie metabolického syndromu. Triton: Praha 2013. ISBN 9788073876784.
Stránská Z, Svačina Š. Myokiny – hormony svalové tkáně. Vnitř Lék 2015; 61(4): 365–368.
Tsai SP, Wen CP, Chan HT et al. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality. Diabetes Res Clin Pract 2008; 82(1): 148–156. Dostupné z DOI: <http://dx.doi.org/10.1016/j.diabres.2008.07.016>.
Awoyemi A, Trøseid M, Arnesen H et al. Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study. Diabetol Metab Syndr 2018; 10: 59. Dostupné z DOI: <http://dx.doi.org/10.1186/s13098–018–0360–3>.
Vishram JK. Prognostic interactions between cardiovascular risk factors. Dan Med J 2014; 61(7): B4892.
Tsai SS, Chu YY, Chen ST et al. A comparison of different definitions of metabolic syndrome for the risks of atherosclerosis and diabetes. Diabetol Metab Syndr 2018; 10: 56. Dostupné z DOI: <http://dx.doi.org/10.1186/s13098–018–0358-x>.
Afifi AE, Shaat RM, Gharbia OM et al Osteoarthritis of knee joint in metabolic syndrome. Clin Rheumatol 2018; 37(10): 2855–2861. Dostupné z DOI: <http://dx.doi.org/10.1007/s10067–018–4201–4>.
Bozzetto L, Costabile G, Della Pepa G et al. Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk. Nutrient 2018; 10(7). pii: E943. Dostupné z DOI: <http://dx.doi.org//10.3390/nu10070943>.
Pérez-Cano HJ, Rubalcava-Soberanis ML, Velázquez Salgado R.. Relationship between blepharitis and components of the metabolic syndrome. Arch Soc Esp Oftalmol 2018; 93(10):476–480. Dostupné z DOI: <http://dx.doi.org//10.1016/j.oftal.2018.06.001>.
Lee CY, Chen HC, Lin HW et al. Blepharitis as an early sign of metabolic syndrome: a nationwide population-based study. Br J Ophthalmol 2018; 102(9):1283–1287. Dostupné z DOI: <http://dx.doi.org/10.1136/bjophthalmol-2017–310975>.
Dhir S, Wangnoo S, Kumar V. Impact of Glycemic Levels in Type 2 Diabetes on Periodontitis. Indian J Endocrinol Metab 2018; 22(5): 672–677. Dostupné z DOI: <http://dx.doi.org/10.4103/ijem.IJEM_566_17>.
Al Saudi RM, Kasabri V, Naffa R et al. Glycated LDL-C and glycated HDL-C in association with adiposity, blood and atherogenicity indices in metabolic syndrome patients with and without prediabetes. Ther Adv Endocrinol Metab 2018; 9(10): 311–323. Dostupné z DOI: <http://dx.doi.org/10.1177/2042018818788198>.
Karen I Svačina Š, Býma S. Prediabetes. Doporučený postup pro praktické lékaře. Centrum doporučených postupů pro praktické lékaře SVL: Praha 2012. ISBN 978–80–86998–56–5.
Chen Z, Wu S, Huang J et al. Metabolic syndrome increases cardiovascular risk in a population with prediabetes: A prospective study in a cohort of Chinese adults. J Diabetes Investig 2018. Dostupné z DOI: <http://dx.doi.org/10.1111/jdi.12958>.
Fried M, Svačina Š et al. Nové trendy v léčbě obesity a diabetu. Axonite: Praha 2018. ISBN 978–80–88046–15–8.